Fever-Tree Shares Fizz Higher After Upbeat AGM Update and Fresh £30m Buyback

Shares in Fever-Tree Drinks (LON: FEVR) surged on Tuesday morning after the premium mixer maker used its Annual General Meeting to deliver a confident trading update and announce a further extension to its share buyback programme.

FEVR stock opened at 821p, rising as high as 823p during the session — a gain of around 43.5p, or 5.7%, from Monday’s closing price of 759p. The move comes on elevated volume, reflecting strong investor enthusiasm for the dual catalyst of positive trading news and returning capital.

The company said it has made a “solid start” to 2026 and remains confident of meeting full-year market expectations for both adjusted revenue and EBITDA.

WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.

Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.

5.0

Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

The Board also announced a £30 million extension to its ongoing share buyback programme — building on the £100 million completed in FY25 and an existing £30 million tranche, of which £18.9 million has already been returned to shareholders.

CEO Tim Warrillow highlighted three key pillars driving optimism. First, the company’s US partnership with Molson Coors is progressing well, with new account wins, growing distribution, and the brand’s first national US marketing campaign launched in April.

Second, the UK diversification strategy is gaining traction, with a new campaign repositioning Fever-Tree as both a mixer and a standalone premium soft drink. Third, the company is well-hedged on costs, with 2026 glass costs fully covered and hedging extended through 2027 and into 2028 — a reassuring signal amid broader geopolitical uncertainty.

Interim results are scheduled for 10 September 2026.